HSV

HSV
Name	Herpes simplex virus
Virus group	DNA virus
Family	Herpesviridae
Genus	Simplexvirus
Species	Herpes simplex virus type 1 and type 2

HSV

Herpes simplex virus is a genus of human pathogens within the family Herpesviridae that cause lifelong infections characterized by episodic mucocutaneous lesions and latent neuronal persistence. The two primary species, historically designated HSV-1 and HSV-2, differ in typical reservoir sites and epidemiological patterns but share conserved replication cycles, immune evasion strategies, and global public health impact. Research on antiviral agents, vaccine candidates, and molecular virology intersects work at institutions such as National Institutes of Health, Centers for Disease Control and Prevention, and university laboratories worldwide.

Virology

HSV belongs to the family Herpesviridae and genus Simplexvirus, with a linear double-stranded DNA genome packaged in an icosahedral capsid surrounded by a tegument and an envelope studded with glycoproteins such as gB, gC, gD, and gH/gL. Structural biology studies using cryo-electron microscopy at facilities like Max Planck Institute and Cold Spring Harbor Laboratory have resolved capsid assembly and glycoprotein conformations critical for entry into host cells such as keratinocytes and sensory neurons. Viral entry engages host receptors including Nectin-1 and HVEM and undergoes membrane fusion mediated by glycoprotein complexes; tegument proteins modulate host transcription and antiviral signaling pathways involving factors characterized in studies from Broad Institute and Salk Institute. HSV establishes latency in sensory ganglia, notably the trigeminal and sacral ganglia, with latency-associated transcripts influencing chromatin structure and episodic reactivation linked to neuronal stressors investigated by researchers at Harvard Medical School and University of California, San Francisco.

Transmission and Epidemiology

HSV is transmitted via direct contact with infectious secretions or lesions during asymptomatic shedding or clinical episodes; typical routes include oral-to-oral, genital sexual contact, and perinatal exposure during delivery. Epidemiological surveys by World Health Organization and UNAIDS report high seroprevalence worldwide with regional variability influenced by factors studied by teams at London School of Hygiene & Tropical Medicine and Johns Hopkins University. Outbreak dynamics intersect public health practice at agencies such as Public Health England and Agence de la santé publique du Canada where surveillance for neonatal herpes and coinfection with pathogens monitored by World Health Organization programs is prioritized. Socioeconomic and behavioral research published in journals supported by Wellcome Trust and Bill & Melinda Gates Foundation has helped map transmission networks and risk factors.

Clinical Manifestations

Primary and recurrent infections produce mucocutaneous lesions: orolabial ulcers classically associated with episodes linked to immunological events described in clinical series from Mayo Clinic and Cleveland Clinic, and genital ulcers associated with cohorts from Kaiser Permanente studies. Complications include herpetic encephalitis, a severe central nervous system syndrome historically characterized in case series from Johns Hopkins Hospital and treated following guidelines from Infectious Diseases Society of America. Neonatal herpes can result in disseminated disease with high morbidity and mortality, prompting obstetric protocols from American College of Obstetricians and Gynecologists. Atypical manifestations such as herpetic keratitis and eczema herpeticum are managed by specialists at centers like Massachusetts Eye and Ear Infirmary and St. Jude Children's Research Hospital.

Diagnosis

Laboratory diagnosis uses nucleic acid amplification tests developed in collaboration between diagnostic companies and academic centers such as Laboratory Corporation of America and Eurofins Scientific; assays target viral DNA from swabs, cerebrospinal fluid, or blood. Viral culture and antigen detection remain available in reference laboratories including those at CDC networks and tertiary hospitals like Mount Sinai Health System, while serologic assays for type-specific glycoprotein G antibodies are used in population studies by investigators at University of Oxford and Karolinska Institutet. Imaging with MRI supports diagnosis of herpes simplex encephalitis in neurological services at Mayo Clinic and Addenbrooke's Hospital.

Treatment and Management

First-line antiviral therapy consists of nucleoside analogues such as acyclovir, valacyclovir, and famciclovir; clinical efficacy and dosing guidelines are informed by randomized trials conducted by groups at NIH and published in journals featuring contributions from Cochrane Collaboration reviews. Severe or encephalitic cases require intravenous acyclovir per protocols used in neuroinfectious disease units at Johns Hopkins Hospital. Management strategies include suppressive therapy to reduce recurrence and transmission, counseling from sexual health services at clinics like Fenway Health, and neonatal management pathways coordinated by obstetric networks such as Royal College of Obstetricians and Gynaecologists.

Prevention and Vaccination

Prevention relies on barrier methods promoted by organizations including Planned Parenthood and public health campaigns by CDC and WHO to reduce transmission risk. Counseling and antenatal screening strategies are implemented in systems like NHS England and Australian Department of Health to identify maternal risk and plan delivery. Vaccine development has involved candidates ranging from recombinant subunit vaccines to live-attenuated and genetic approaches evaluated in trials sponsored by Moderna, GlaxoSmithKline, and academic consortia at University of Pennsylvania; despite decades of effort described in reviews from Lancet and New England Journal of Medicine, a widely approved prophylactic HSV vaccine remains elusive.

History and Research Developments

Descriptions of herpetic disease date to classical texts and evolved through virology milestones at institutions such as Pasteur Institute and Rockefeller University where early viral culture methods and immunologic concepts were developed. Molecular cloning of HSV genomes and discovery of latency mechanisms were advanced by laboratories at Stanford University and Yale University, while antiviral drug discovery traces through pharmaceutical history involving companies like Burroughs Wellcome and regulatory approvals coordinated by Food and Drug Administration. Ongoing research focuses on gene-editing approaches, therapeutic vaccines, and immune modulators pursued at centers including MIT, Cold Spring Harbor Laboratory, and European Molecular Biology Laboratory.

Category:Herpesviridae